Skip to main content

Table 1 The status of RR-TB detection, FQs resistance testing and PMDT coverage in China, 2015–2019

From: Characteristics of rifampicin-resistant tuberculosis detection in China, 2015–2019

Year RR-TB cases detected RR screening rate (%) Proportion of FQs screening in RR-TB cases (%) Prefecture-level coverage rate for PMDT (%)
All New cases
n (%)
High-risk groups
n (%)
All New cases High-risk groups All New cases High-risk groups
2015 10 019 3971 (39.6) 6048 (60.4) 29.5 23.1 57.3 57.8 58.6 57.2 70.0
2016 11 423 4564 (40.0) 6859 (60.0) 28.6 22.8 54.8 59.6 60.3 59.0 70.0
2017 13 069 6227 (47.6) 6842 (52.4) 37.8 33.1 57.2 51.9 52.7 51.1 78.0
2018 15 066 7807 (51.8) 7259 (48.2) 62.8 60.2 72.6 48.2 51.3 45.0 90.0
2019 18 623 10 204 (54.8) 8419 (45.2) 81.9 80.4 88.4 41.0 42.7 39.0 95.0
Total 68 200 32 773 (48.1) 35 427 (51.9) 49.4 45.3 67.2 50.3 51.0 49.6
  1. RR-TB Rifampicin-resistant tuberculosis, FQs Fluoroquinolones, PMDT Programmatic Management of Drug-resistant Tuberculosis